文献速递儿科与产科急症

美国整合医疗系统中COVID-19大流行前后孕妇及新生儿产前保健结局

Prenatal Health Care Outcomes Before and During the COVID-19 Pandemic Among Pregnant Individuals and Their Newborns in an Integrated US Health System.
PubMed 文献 · JAMA Netw Open · 2023-07-03
一句话结论在Kaiser Permanente Northern California整合医疗系统中,结合诊室与远程医疗的多模式产前保健模式与仅诊室产前保健相比表现相当,支持大流行后继续使用。

该队列研究纳入2018年7月1日至2021年10月21日在Kaiser Permanente Northern California分娩活产或死胎的151464名孕妇,按多模式产前保健模式暴露程度分为未暴露(T1)、部分暴露(T2)和完全暴露(T3)三个时段。结果显示,三个时段平均产前访视总数相似(T1 9.41次、T2 9.17次、T3 9.15次),远程医疗访视比例从T1的11.1%升至T2的20.9%和T3的21.3%。中断时间序列分析显示,子痫前期和子痫、严重孕产妇发病率、剖宫产、早产及次要结局的风险在三个时段均无临床相关变化;NICU入住风险在T1无变化(每4周变化-0.22%,95%CI -0.53%至0.09%),T2下降(-0.91%,95%CI -1.77%至-0.03%),T3上升(1.75%,95%CI 0.49%至3.02%)。作者认为该多模式产前保健模式表现相当,支持大流行后继续使用。

要点

  • 队列纳入151464名孕妇,平均(SD)年龄31.3(5.3)岁,分娩活产或死胎,暴露按多模式产前保健模式分为T1未暴露、T2部分暴露、T3完全暴露三个时段。
  • 远程医疗访视比例从T1的11.1%(79214次访视)升至T2的20.9%(66726次访视)和T3的21.3%(79518次访视),平均产前访视总数相似(T1 9.41次、T2 9.17次、T3 9.15次)。
  • NICU入住率T1为9.2%(7014例)、T2为8.3%(2905例)、T3为8.6%(3615例);中断时间序列显示NICU入住风险T1无变化(每4周-0.22%,95%CI -0.53%至0.09%)、T2下降(-0.91%,95%CI -1.77%至-0.03%)、T3上升(1.75%,95%CI 0.49%至3.02%)。
  • 子痫前期和子痫、严重孕产妇发病率、剖宫产、早产及次要结局在T1、T2、T3间无临床相关变化(各时段每4周变化值及95%CI见原文)。
  • 作者认为结合诊室与远程医疗的多模式产前保健模式与仅诊室产前保健相比表现相当,支持大流行后继续使用。

适用人群与场景

  • 2018年7月1日至2021年10月21日在Kaiser Permanente Northern California分娩活产或死胎的孕妇,该整合医疗系统服务450万人。

研究设计与关键结果

  • 研究类型:利用纵向电子健康记录数据的队列研究,在Kaiser Permanente Northern California进行,纳入151464名分娩活产或死胎的孕妇,平均(SD)年龄31.3(5.3)岁,数据分析时间为2022年1月至2023年5月。
  • 暴露分组:未暴露(T1,2018年7月1日至2020年2月29日分娩)、部分暴露(T2,2020年3月1日至2020年12月5日分娩)、完全暴露(T3,2020年12月6日至2021年10月31日分娩)。
  • 主要结局:子痫前期和子痫、严重孕产妇发病率、剖宫产、早产、新生儿重症监护病房(NICU)入住率。
  • 平均(SD)产前访视总数:T1 9.41(4.75)次、T2 9.17(4.50)次、T3 9.15(4.66)次;远程医疗访视比例:T1 11.1%(79214次访视)、T2 20.9%(66726次访视)、T3 21.3%(79518次访视)。
  • NICU入住率:T1 9.2%(7014例)、T2 8.3%(2905例)、T3 8.6%(3615例)。
  • 中断时间序列分析显示NICU入住风险:T1每4周变化-0.22%(95%CI -0.53%至0.09%),T2每4周变化-0.91%(95%CI -1.77%至-0.03%),T3每4周变化1.75%(95%CI 0.49%至3.02%)。
  • 子痫前期和子痫风险每4周变化:T1 0.76%(95%CI 0.39%至1.14%)、T2 -0.19%(95%CI -1.19%至0.81%)、T3 -0.80%(95%CI -2.13%至0.55%);严重孕产妇发病率每4周变化:T1 0.12%(95%CI 0.40%至0.63%)、T2 -0.39%(95%CI -1.00%至1.80%)、T3 0.99%(95%CI -0.88%至2.90%);剖宫产每4周变化:T1 0.06%(95%CI -0.11%至0.23%)、T2 -0.03%(95%CI -0.49%至0.44%)、T3 -0.05%(95%CI -0.68%至0.59%);早产每4周变化:T1 0.23%(95%CI -0.11%至0.57%)、T2 -0.37%(95%CI -1.29%至0.55%)、T3 -0.15%(95%CI -1.41%至1.13%);

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,结合诊室与远程医疗的多模式产前保健模式与仅诊室产前保健相比表现相当,支持其在大流行后继续使用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The COVID-19 pandemic accelerated the use of telemedicine. However, data on the integration of telemedicine in prenatal health care and health outcomes are sparse.

OBJECTIVE: To evaluate a multimodal model of in-office and telemedicine prenatal health care implemented during the COVID-19 pandemic and its association with maternal and newborn health outcomes.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study of pregnant individuals using longitudinal electronic health record data was conducted at Kaiser Permanente Northern California, an integrated health care system serving a population of 4.5 million people. Individuals who delivered a live birth or stillbirth between July 1, 2018, and October 21, 2021, were included in the study. Data were analyzed from January 2022 to May 2023.

EXPOSURE: Exposure levels to the multimodal prenatal health care model were separated into 3 intervals: unexposed (T1, birth delivery between July 1, 2018, and February 29, 2020), partially exposed (T2, birth delivery between March 1, 2020, and December 5, 2020), and fully exposed (T3, birth delivery between December 6, 2020, and October 31, 2021).

MAIN OUTCOMES AND MEASURES: Primary outcomes included rates of preeclampsia and eclampsia, severe maternal morbidity, cesarean delivery, preterm birth, and neonatal intensive care unit (NICU) admission. The distributions of demographic and clinical characteristics, care processes, and health outcomes for birth deliveries within each of the 3 intervals of interest were assessed with standardized mean differences calculated for between-interval contrasts. Interrupted time series analyses were used to examine changes in rates of perinatal outcomes and its association with the multimodal prenatal health care model. Secondary outcomes included gestational hypertension, gestational diabetes, depression, venous thromboembolism, newborn Apgar score, transient tachypnea, and birth weight.

RESULTS: The cohort included 151 464 individuals (mean [SD] age, 31.3 [5.3] years) who delivered a live birth or stillbirth. The mean (SD) number of total prenatal visits was similar in T1 (9.41 [4.75] visits), T2 (9.17 [4.50] visits), and T3 (9.15 [4.66] visits), whereas the proportion of telemedicine visits increased from 11.1% (79 214 visits) in T1 to 20.9% (66 726 visits) in T2 and 21.3% (79 518 visits) in T3. NICU admission rates were 9.2% (7014 admissions) in T1, 8.3% (2905 admissions) in T2, and 8.6% (3615 admissions) in T3. Interrupted time series analysis showed no change in NICU admission risk during T1 (change per 4-week interval, -0.22%; 95% CI, -0.53% to 0.09%), a decrease in risk during T2 (change per 4-week interval, -0.91%; 95% CI, -1.77% to -0.03%), and an increase in risk during T3 (change per 4-week interval, 1.75%; 95% CI, 0.49% to 3.02%). There were no clinically relevant changes between T1, T2, and T3 in the rates of risk of preeclampsia and eclampsia (change per 4-week interval, 0.76% [95% CI, 0.39% to 1.14%] for T1; -0.19% [95% CI, -1.19% to 0.81%] for T2; and -0.80% [95% CI, -2.13% to 0.55%] for T3), severe maternal morbidity (change per 4-week interval , 0.12% [95% CI, 0.40% to 0.63%] for T1; -0.39% [95% CI, -1.00% to 1.80%] for T2; and 0.99% [95% CI, -0.88% to 2.90%] for T3), cesarean delivery (change per 4-week interval, 0.06% [95% CI, -0.11% to 0.23%] for T1; -0.03% [95% CI, -0.49% to 0.44%] for T2; and -0.05% [95% CI, -0.68% to 0.59%] for T3), preterm birth (change per 4-week interval, 0.23% [95% CI, -0.11% to 0.57%] for T1; -0.37% [95% CI, -1.29% to 0.55%] for T2; and -0.15% [95% CI, -1.41% to 1.13%] for T3), or secondary outcomes.

CONCLUSIONS AND RELEVANCE: These findings suggest that a multimodal prenatal health care model combining in-office and telemedicine visits performed adequately compared with in-office only prenatal health care, supporting its continued use after the pandemic.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Ferrara A, Greenberg M, Zhu Y, et al. Prenatal Health Care Outcomes Before and During the COVID-19 Pandemic Among Pregnant Individuals and Their Newborns in an Integrated US Health System. JAMA Netw Open. 2023. PMID: 37462973. doi:10.1001/jamanetworkopen.2023.24011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。